Insider Transactions in Q1 2025 at Kymera Therapeutics, Inc. (KYMR)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jan 10
2025
|
Bruce N. Jacobs Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.29%
|
$20,000
$2.08 P/Share
|
Jan 10
2025
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+1.49%
|
$20,000
$2.08 P/Share
|
Jan 06
2025
|
Ellen Chiniara Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,129
-5.4%
|
$128,289
$41.75 P/Share
|